- Home
- FBRX vs ICMB Comparison
FBRX vs ICMB Comparison
Compare FBRX & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- ICMB
- Stock Information
- Founded
- FBRX N/A
- ICMB 2012
- Country
- FBRX United States
- ICMB United States
- Employees
- FBRX N/A
- ICMB N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- FBRX Health Care
- ICMB Finance
- Exchange
- FBRX Nasdaq
- ICMB Nasdaq
- Market Cap
- FBRX 44.8M
- ICMB 41.1M
- IPO Year
- FBRX N/A
- ICMB N/A
- Fundamental
- Price
- FBRX $10.05
- ICMB $2.71
- Analyst Decision
- FBRX Strong Buy
- ICMB
- Analyst Count
- FBRX 3
- ICMB 0
- Target Price
- FBRX $80.50
- ICMB N/A
- AVG Volume (30 Days)
- FBRX 67.3K
- ICMB 46.2K
- Earning Date
- FBRX 05-15-2025
- ICMB 05-13-2025
- Dividend Yield
- FBRX N/A
- ICMB 17.81%
- EPS Growth
- FBRX N/A
- ICMB N/A
- EPS
- FBRX N/A
- ICMB 0.82
- Revenue
- FBRX N/A
- ICMB $20,996,189.00
- Revenue This Year
- FBRX N/A
- ICMB N/A
- Revenue Next Year
- FBRX N/A
- ICMB N/A
- P/E Ratio
- FBRX N/A
- ICMB $3.27
- Revenue Growth
- FBRX N/A
- ICMB N/A
- 52 Week Low
- FBRX $4.11
- ICMB $2.46
- 52 Week High
- FBRX $28.68
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- FBRX 63.47
- ICMB 43.04
- Support Level
- FBRX $7.78
- ICMB $2.66
- Resistance Level
- FBRX $13.84
- ICMB $2.82
- Average True Range (ATR)
- FBRX 1.38
- ICMB 0.10
- MACD
- FBRX 0.20
- ICMB -0.02
- Stochastic Oscillator
- FBRX 50.44
- ICMB 18.18
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.